Solta Medical, Inc.
25881 Industrial Boulevard
Hayward,
CA 94545-2991
United States - Map
Phone: 510-782-2286
Fax: 510-782-2287
Web Site: http://www.solta.com
| Solta Medical, Inc. designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications. Its products include Thermage NXT system that provides non-invasive treatment options for skin tightening and contouring, body shaping, and enhancement in the appearance of cellulite; Fraxel re:fine and Fraxel re:store systems, which offer treatments for skin conditions, such as fine lines and pigmentation; and Fraxel re:pair system for dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, as well as for rhytids, pigmentation, and vascular dyschromia. The companys Fraxel re:store system also offers treatments for acne and surgical scars, deeper lines and wrinkles, and actinic keratoses. Its systems consist of one or more handpieces, a console that incorporates a graphical user interface, an energy source and electronics, and a disposable treatment tip. The companys customers include dermatologists, plastic surgeons, general and family practitioners, gynecologists, and ophthalmologists. Solta Medical markets its systems and treatment tips through direct sales force and a network of distributors in the United States and internationally. The company was formerly known as Thermage, Inc. and changed its name to Solta Medical, Inc. in January 2009. Solta Medical was founded in 1995 and is headquartered in Hayward, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Stephen J. Fanning , 57
Exec. Chairman, Chief Exec. Officer and Pres |
$
540.00K |
$
0 | Dr. Edward W. Knowlton M.D., 60
Founder, Director and Member of Scientific Advisory Board |
$
33.00K | N/A | Mr. John F. Glenn , 47
Chief Financial Officer |
$
289.00K |
$
0 | Mr. Clint Carnell , 39
Chief Operating Officer |
$
330.00K |
$
0 | Mr. Leonard C. DeBenedictis , 68
Chief Technology Officer |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.22% Nasdaq 
0.05 (2.53%) 
Profile
